Cargando…

Immunosuppression-associated primary cutaneous plasmablastic lymphoma secondary to romidepsin

Detalles Bibliográficos
Autores principales: Costello, Collin M., Maly, Connor J., Snider, Sam, Severson, Kevin J., DiCaudo, David J., Rosenthal, Allison C., Northfelt, Donald W., Rule, William, Craig, Fiona E., Pittelkow, Mark R., Mangold, Aaron R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6938883/
https://www.ncbi.nlm.nih.gov/pubmed/31909131
http://dx.doi.org/10.1016/j.jdcr.2019.10.022
_version_ 1783484121450807296
author Costello, Collin M.
Maly, Connor J.
Snider, Sam
Severson, Kevin J.
DiCaudo, David J.
Rosenthal, Allison C.
Northfelt, Donald W.
Rule, William
Craig, Fiona E.
Pittelkow, Mark R.
Mangold, Aaron R.
author_facet Costello, Collin M.
Maly, Connor J.
Snider, Sam
Severson, Kevin J.
DiCaudo, David J.
Rosenthal, Allison C.
Northfelt, Donald W.
Rule, William
Craig, Fiona E.
Pittelkow, Mark R.
Mangold, Aaron R.
author_sort Costello, Collin M.
collection PubMed
description
format Online
Article
Text
id pubmed-6938883
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-69388832020-01-06 Immunosuppression-associated primary cutaneous plasmablastic lymphoma secondary to romidepsin Costello, Collin M. Maly, Connor J. Snider, Sam Severson, Kevin J. DiCaudo, David J. Rosenthal, Allison C. Northfelt, Donald W. Rule, William Craig, Fiona E. Pittelkow, Mark R. Mangold, Aaron R. JAAD Case Rep Case Report Elsevier 2019-12-24 /pmc/articles/PMC6938883/ /pubmed/31909131 http://dx.doi.org/10.1016/j.jdcr.2019.10.022 Text en © 2019 by the American Academy of Dermatology, Inc. Published by Elsevier, Inc. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Costello, Collin M.
Maly, Connor J.
Snider, Sam
Severson, Kevin J.
DiCaudo, David J.
Rosenthal, Allison C.
Northfelt, Donald W.
Rule, William
Craig, Fiona E.
Pittelkow, Mark R.
Mangold, Aaron R.
Immunosuppression-associated primary cutaneous plasmablastic lymphoma secondary to romidepsin
title Immunosuppression-associated primary cutaneous plasmablastic lymphoma secondary to romidepsin
title_full Immunosuppression-associated primary cutaneous plasmablastic lymphoma secondary to romidepsin
title_fullStr Immunosuppression-associated primary cutaneous plasmablastic lymphoma secondary to romidepsin
title_full_unstemmed Immunosuppression-associated primary cutaneous plasmablastic lymphoma secondary to romidepsin
title_short Immunosuppression-associated primary cutaneous plasmablastic lymphoma secondary to romidepsin
title_sort immunosuppression-associated primary cutaneous plasmablastic lymphoma secondary to romidepsin
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6938883/
https://www.ncbi.nlm.nih.gov/pubmed/31909131
http://dx.doi.org/10.1016/j.jdcr.2019.10.022
work_keys_str_mv AT costellocollinm immunosuppressionassociatedprimarycutaneousplasmablasticlymphomasecondarytoromidepsin
AT malyconnorj immunosuppressionassociatedprimarycutaneousplasmablasticlymphomasecondarytoromidepsin
AT snidersam immunosuppressionassociatedprimarycutaneousplasmablasticlymphomasecondarytoromidepsin
AT seversonkevinj immunosuppressionassociatedprimarycutaneousplasmablasticlymphomasecondarytoromidepsin
AT dicaudodavidj immunosuppressionassociatedprimarycutaneousplasmablasticlymphomasecondarytoromidepsin
AT rosenthalallisonc immunosuppressionassociatedprimarycutaneousplasmablasticlymphomasecondarytoromidepsin
AT northfeltdonaldw immunosuppressionassociatedprimarycutaneousplasmablasticlymphomasecondarytoromidepsin
AT rulewilliam immunosuppressionassociatedprimarycutaneousplasmablasticlymphomasecondarytoromidepsin
AT craigfionae immunosuppressionassociatedprimarycutaneousplasmablasticlymphomasecondarytoromidepsin
AT pittelkowmarkr immunosuppressionassociatedprimarycutaneousplasmablasticlymphomasecondarytoromidepsin
AT mangoldaaronr immunosuppressionassociatedprimarycutaneousplasmablasticlymphomasecondarytoromidepsin